Historical Archive

Pharmaceuticals: Ucb sells production sites in Italy and Germany

 The Milan office of UCB, in via Gadames


Involved Pianezza plant (Turin) (Il Sole 24 Ore Radiocor) – Brussels, Dec 15 – The Belgian group ucb sold three production units, two in Germany and one in Italy, which employ a total of 600 workers, to the British Aesica. Thus a note from the Belgian company, which specifies that the three sites are located in Monheim and Zwickau, in Germany, and in Pianezza (Turin). The employees, he specified, "will continue their work and will be transferred to Aesica". The operation should be formalized within the first quarter of 2011. UCB explained "that it no longer needs to have large production units for chemicals, while its needs at the biotechnological level are increasing". UCB specializes in the treatment of diseases of the central nervous system and in immunology. Red-pal (RADIOCOR) 12-15-10 16:38:35 (0327) 5 NNNN

Editor's note: Baron Daniel Janssen is the reference shareholder of Solvay and, through Financier de Tubize, of UCB. André and his brother Eric hold the position of Honorary Directors at UCB. The constellation Solvay – Janssen – Boël, all descendants by blood or marriage, direct and indirect skillfully composed by Ernest Solvay (1838-1922), through an intricate network of cross-shareholdings controls in the fields of chemistry (Solvay, UCB), finance (Sofina Puilaetco), banking (General Bank), heavy industry (Mills Gustave Boël) Construction (Etex Group, ex Eternit), retail (GIB ), agri-food (Sipef Interbrew). UCB Italy 2 years ago put all the ISF of "primary care" into mobility.


Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco